0001104659-21-077205.txt : 20210604 0001104659-21-077205.hdr.sgml : 20210604 20210604175019 ACCESSION NUMBER: 0001104659-21-077205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210602 FILED AS OF DATE: 20210604 DATE AS OF CHANGE: 20210604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CORRIGAN MARK CENTRAL INDEX KEY: 0001250661 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 21997649 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2118134-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-06-02 0 0001641640 Nabriva Therapeutics plc NBRV 0001250661 CORRIGAN MARK 414 COMMERCE DR. SUITE 120 FORT WASHINGTON PA 19034 1 0 0 0 Share Options 1.39 2021-06-02 4 A 0 10500 0 A 2031-06-01 Ordinary Shares 10500 10500 D The option was granted on June 2, 2021. The option will vest over a three-year period on a monthly pro rata basis beginning on June 2, 2021 and subject to the Reporting Person's continued service on the board of directors of the Issuer. /s/ Robert Crotty, by power of attorney 2021-06-04